Domain Therapeutics to Participate in Upcoming Investor and Industry Conferences

Strasbourg, France – Montreal, Canada, February 6th, 2023 – Domain Therapeutics (“Domain” or “the Company”), a drug discovery and development company focused on G Protein-Coupled Receptors (GPCRs) in immuno-oncology (IO), today announces investor and industry conferences that its Chief Executive Officer, Pascal Neuville, will attend or speak at in the first half of 2023.

OBIO Investor Summit, World Trade Centre, Toronto, Canada – 8-9 February

  • Presentation slot: February 9th, 3:30 p.m., Room C/D

LSX World Congress, London, UK – 3-4 May

Bio€quity, Dublin, Ireland – 14-16 May

  • Presentation slot: to be announced at a later date


– ENDS –

For more information, please contact:

Consilium Strategic Communications
Amber Fennell, Namrata Taak, Maya Bennison
Tel: +44 (0)20 3709 5813


NewCap (for French media)
Annie-Florence Loyer
Tel: +33 (0)

Download the pdf